Transcatheter Cardiovascular Therapeutics (TCT)

The Transcatheter Cardiovascular Therapeutics (TCT) conference is the Cardiovascular Research Foundation's (CRF) annual scientific symposium and the largest conference focused on interventional cardiovascular medicine. TCT includes seminars on all areas of intervention cardiology, structural heart, vascular in interventions, peripheral artery disease, and other procedures in the cath lab.

SCAI fighting for interventional cardiologists amid challenging payment policies
SCAI President Srihari Naidu, MD, detailed some of the challenges interventional cardiologists face as reimbursements keep declining. The group has been building new partnerships with other medical societies to strengthen its influence in Washington.
AI dramatically improves the detection of severe heart attacks
Researchers put an advanced AI model to the test, using it to evaluate the ECG results of more than 1,000 patients. It performed quite well.
Interventional cardiology showing more interest in endovascular procedures
Sahil Parikh, MD, said it was clear at TCT 2025 that the specialty is getting more and more involved with endovascular procedures for stroke, pulmonary embolism and peripheral artery disease.
CCTA will play an essential role in the cath labs of the future
Noninvasive coronary CT angiography is growing more and more important as time goes on, helping cardiologists make critical treatment decisions. Carlos Collet, MD, PhD, discussed the technique's potential to be a real game-changer for patient care in a new interview.
Mechanical thrombectomy beats anticoagulation alone in STORM-PE
Highly anticipated trial data comparing mechanical thrombectomy to anticoagulation alone for intermediate- and high-risk pulmonary embolism showed that the more aggressive strategy improved outcomes.

SCAI President Srihari S. Naidu, MD, professor of medicine at New York Medical College, explained some of the key payment issues interventional cardiologists are facing amid declining Medicare reimbursements.

SCAI fighting for interventional cardiologists amid challenging payment policies

SCAI President Srihari Naidu, MD, detailed some of the challenges interventional cardiologists face as reimbursements keep declining. The group has been building new partnerships with other medical societies to strengthen its influence in Washington.

artificial intelligence AI heart cardiology

AI dramatically improves the detection of severe heart attacks

Researchers put an advanced AI model to the test, using it to evaluate the ECG results of more than 1,000 patients. It performed quite well.

Sahil Parikh, MD, director of endovascular services, Columbia University Irving Medical Center, associate professor of medicine at Columbia University, and a program director for the Transcatheter Cardiovascular Therapeutics (TCT) meeting, explains the growing focus in interventional cardiology on endovascular procedures for stroke, pulmonary embolism, peripheral artery disease and renal denervation.

Interventional cardiology showing more interest in endovascular procedures

Sahil Parikh, MD, said it was clear at TCT 2025 that the specialty is getting more and more involved with endovascular procedures for stroke, pulmonary embolism and peripheral artery disease.

Carlos Collet, MD, PhD, director, cardiovascular imaging, physiology and translational therapeutics, Cardiovascular Research Foundation, explains how noninvasive coronary CT angiography (CCTA) assessments will play a major role to eliminate invasive diagnostic angiography and to pre-plan percutaneous coronary intervention (PCI) procedures.

CCTA will play an essential role in the cath labs of the future

Noninvasive coronary CT angiography is growing more and more important as time goes on, helping cardiologists make critical treatment decisions. Carlos Collet, MD, PhD, discussed the technique's potential to be a real game-changer for patient care in a new interview.

Video Robert Lookstein on mechanical thrombectomy beating anticoagulation alone in pulmonary embolism in the late-breaking STORM-PE trial at TCT 2025.

Mechanical thrombectomy beats anticoagulation alone in STORM-PE

Highly anticipated trial data comparing mechanical thrombectomy to anticoagulation alone for intermediate- and high-risk pulmonary embolism showed that the more aggressive strategy improved outcomes.

At the recent American College of Cardiology (ACC) Legislative Committee meeting, leaders warned that ongoing federal policy uncertainty threatens patient access and the stability of cardiovascular care. Cathie Biga, MSM, immediate past president of the ACC, outlined growing concerns over telehealth, shrinking Medicare reimbursement, and mounting physician workforce shortages driven by visa restrictions.

ACC raises red flags over telehealth, payment reform and the cardiologist shortage

"We need telehealth the way we had it for COVID," Cathie Biga told Cardiovascular Business at TCT 2025. "We don't want to go back to having it so restricted."

Hadley Wilson, MD, MACC, executive vice chair of Atrium Health Sanger Heart and Vascular Institute, and a clinical professor of medicine at Wake Forest University School of Medicine, shares what he felt were the most important clinical trials presented at the TCT 2025.

Key takeaways for interventional cardiology from TCT 2025

B. Hadley Wilson, MD, talked to Cardiovascular Business about several standout late-breaking clinical trials presented at TCT 2025. Topics of those trials included drug-coated balloons, TAVR valve durability, pulmonary embolism treatments and much more.

Paradise Ultrasound image courtesy of Recor Medical.

More good news for renal denervation: FDA-approved systems linked to positive long-term data

New data on the RDN systems from Recor Medical and Medtronic confirmed that this relatively new technology brings long-term relief to patients with uncontrolled hypertension.